Status:
COMPLETED
Type 2 Diabetes and Bone Microarchitecture
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
Brief Summary
Type 2 diabetes is a major public health problem, associated with an increased risk of fractures. Diabetes even appears to be the most important predictor of low kinetic fractures in men and women, an...
Eligibility Criteria
Inclusion
- Men and women included in the 3 cohorts (QUALYOR, OFELY, STRAMBO) presenting type 2 diabetes
- Age- and sex-matched control patients from the same cohorts without type 2 diabetes ; two control were age- and sex-matched to one type 2 diabetes patient.
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
582 Patients enrolled
Trial Details
Trial ID
NCT04765631
Start Date
January 1 2020
End Date
July 1 2020
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
INSERM U1033, pavillon F, Hôpital E. Herriot. 5, place d'Arsonval
Lyon, France, 69437